Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.45 |
| ▸ | CA2 | P00918 | 3/20 | 0.45 |
| ▸ | HTR6 | P50406 | 3/20 | 0.44 |
| ▸ | HRH1 | P35367 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.38 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30317399 | 0.84 | FABP4 (0.53) | — | |
| SCHEMBL30317485 | 0.81 | FABP4 (0.52) | — | |
| SCHEMBL26246955 | 0.80 | CA1 (0.42) | CA1CA2HTR6MEN1KMT2A | |
| SCHEMBL26246952 | 0.80 | FABP4 (0.51) | CA1CA2HTR6MEN1KMT2A | |
| SCHEMBL28983423 | 0.75 | FABP4 (0.48) | KMT2A | |
| SCHEMBL30317372 | 0.75 | FABP4 (0.48) | KMT2A | |
| SCHEMBL8033028 | 0.70 | HRH1 (0.72) | CA1CA2HTR6HRH1MEN1 | |
| SCHEMBL30317288 | 0.70 | FABP4 (0.59) | — | |
| SCHEMBL4127989 | 0.70 | HRH1 (0.83) | HTR6HRH1MEN1KMT2AHDAC6 | |
| SCHEMBL24155512 | 0.69 | FABP4 (0.68) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4175647-A1 | ANTIVIRAL USE OF FABP4 MODULATING COMPOUNDS | Crescenta Biosciences (US) | 2023-05-10 | — | — | EP | disclosed |